|
Bristol-Myers Squibb and PsiOxus Therapeutics announce immuno-oncology clinical collaboration
|
30 June 2016 |
|
Ready. Raise. Rise. Campaign
|
06 May 2016 |
|
Bristol-Myers Squibb reports first quarter financial results
|
28 April 2016 |
|
Bristol-Myers Squibb to acquire Padlock Therapeutics, Inc.
|
23 March 2016 |
|
Bristol-Myers Squibb and LabCentral team up in Cambridge, Massachusetts to support promising biotech startup companies
|
07 March 2016 |
|
Bristol-Myers Squibb completes previously announced sale of its HIV R&D portfolio to ViiV Healthcare
|
22 February 2016 |
|
Bristol-Myers Squibb and Dana-Farber Cancer Institute enter into a collaboration agreement
|
16 February 2016 |
|
Bristol-Myers Squibb Foundation awards eight grants totaling nearly $11.5M to make lung and skin cancer screening
|
01 February 2016 |
|
Bristol-Myers Squibb to sell its HIV R&D portfolio to ViiV Healthcare
|
18 December 2015 |
|
Bristol-Myers Squibb and UCLA enter into a collaboration agreement
|
14 December 2015 |
|
Bristol-Myers Squibb Foundation marks World AIDS Day with grants totaling more than $3.5M
|
01 December 2015 |
|
Bristol-Myers Squibb to acquire Cardioxyl Pharmaceuticals, Inc.
|
02 November 2015 |
|
Bristol-Myers Squibb reports third quarter financial results
|
27 October 2015 |
|
Bristol-Myers Squibb's Opdivo (nivolumab) receives expanded FDA approval in previously-treated metastatic non-small cell lung cancer (NSCLC)
|
12 October 2015 |
|
Bristol-Myers Squibb and Moffitt Cancer Center enter into a collaboration agreement
|
25 September 2015 |
|
Bristol-Myers Squibb Employees cycle nearly 2,900 miles to raise money for cancer research
|
10 September 2015 |
|
Bristol-Myers Squibb establishes collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) program in the U.S.
|
04 August 2015 |
|
Lilly, Bristol-Myers Squibb Restructure Erbitux® (cetuximab) Collaboration in North America
|
16 April 2015 |
|
Bristol-Myers Squibb acquires exclusive license from Novo Nordisk for a discovery research program focused on autoimmune diseases
|
24 March 2015 |
|
FDA approves Opdivo (nivolumab) for the treatment of patients with previously treated metastatic squamous non-small cell lung cancer
|
05 March 2015 |